Abstract
Systematic prostate biopsy has revolutionized our ability to detect prostate cancer. Sextant biopsies were the mainstay of cancer detection since their inception in 1989. Over the past several years more extensive systematic prostate sampling has been introduced and has demonstrated an improved ability to detect prostate cancer. The optimal prostate biopsy scheme should be easy to perform, be able to be done in the clinic without intravenous sedation or general anesthetic, provide a high sensitivity for cancer detection, and have a low complication rate. We review several studies evaluating various biopsy schemes for both initial and repeat biopsy patients and propose an optimal biopsy scheme.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Urologic Oncology: Seminars and Original Investigations
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
